PHYSICAL THERAPY IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH): RESULTS FROM A GERMAN CLAIMS DATA ANALYSIS

被引：0
|
作者：
Barthuber, L. [1 ]
Nill, I [1 ]
Jacob, C. [2 ]
Schmid, T. [1 ]
机构：
[1] MSD Sharp & Dohme GmbH, Munich, By, Germany
[2] Xcenda GmbH, Hannover, Germany
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HSD44
引用
收藏
页码：S334 / S334
页数：1
相关论文
共 50 条
  • [41] The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients
    Sikirica, Mirko
    Iorga, Serban R.
    Bancroft, Tim
    Potash, Jesse
    BMC HEALTH SERVICES RESEARCH, 2014, 14
  • [42] Hemodynamic effects of sildenafil citrate in patients with pulmonary arterial hypertension (PAH)
    Rubin, L
    Burgess, G
    Parpia, T
    Burst, R
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 93A - 94A
  • [43] Patients with pulmonary arterial hypertension (PAH) have poor sleep quality
    Pandya, CM
    Minai, OA
    Golish, JA
    McCarthy, K
    CHEST, 2005, 128 (04) : 382S - 383S
  • [44] The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients
    Mirko Sikirica
    Serban R Iorga
    Tim Bancroft
    Jesse Potash
    BMC Health Services Research, 14
  • [45] Successful management of pregnancy in six patients with pulmonary arterial hypertension (PAH)
    Zwicke, DL
    Buggy, BP
    Evans, W
    CHEST, 2003, 124 (04) : 89S - 89S
  • [46] Economic Burden of Delayed Diagnosis in Patients with Pulmonary Arterial Hypertension (PAH)
    Hilary M. DuBrock
    Hayley D. Germack
    Marjolaine Gauthier-Loiselle
    Jörg Linder
    Ambika Satija
    Ameur M. Manceur
    Martin Cloutier
    Patrick Lefebvre
    Sumeet Panjabi
    Robert P. Frantz
    PharmacoEconomics - Open, 2024, 8 : 133 - 146
  • [47] Co-morbidities and pulmonary arterial hypertension (PAH) in COPD patients
    Stratev, Velin
    Dobreva, Tanya
    Dimitrova, Valentina
    Petkova, Diana
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [48] Thyroid disease and pulmonary arterial hypertension (PAH) in patients treated with prostacyclin
    Ferris, AM
    Morse, JH
    Jacobs, T
    Rosenzweig, EB
    Aranoff, GS
    Barst, RJ
    CIRCULATION, 2000, 102 (18) : 426 - 427
  • [49] Initial Triple Oral Therapy in Pulmonary Arterial Hypertension (PAH): Extended Long-Term Outcome Data from TRITON
    McLaughlin, V.
    Chin, K.
    Doelberg, M.
    Galie, N.
    Hoeper, M. M.
    Mathai, S. C.
    Perchenet, L.
    Simonneau, G.
    Sitbon, O.
    Martin, N.
    Gibbs, J. S. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S108 - S108
  • [50] Concomitant initiation of combination therapy with macitentan and tadalafil in pulmonary arterial hypertension (PAH) patients with comorbidities: real-world data from OPUS and OrPHeUS
    Channick, R.
    Chin, K. M.
    Kim, N. H.
    Ong, R.
    Turricchia, S.
    Mitchell, L.
    McLaughlin, V. V.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1916 - 1916
12345